The nations of the European Union launched a coordinated effort on Sunday to administer the COVID-19 vaccine to the most vulnerable among the bloc’s nearly 450 million inhabitants, marking a moment of hope in the continent’s battle against the worst crisis in public health in a century. Healthcare workers, the …
Read More »AstraZeneca Vaccine Has ‘Winning Formula’, Provides ‘100% Protection’ Against Severe Covid-19: CEO
A small shopping basket filled with vials labeled “COVID-19 – Coronavirus Vaccine” and medical sryinges are placed on an AstraZeneca logo in this illustration taken on November 29, 2020. (REUTERS / Dado Ruvic / Illustration) The Oxford-AstraZeneca vaccine, which is currently under evaluation by Britain’s independent drug regulator, provides “100 …
Read More »Oxford Covid-19 Vaccine May Become First To Get Indian Regulator Clearance For Emergency Use
With preparations underway for a possible January launch of the vaccine, India’s drug regulator is looking into the UK, which sources say may give the Oxford Covid-19 vaccine its go-ahead next week, ahead of decide to grant emergency use authorization to the Serum Institute. who is manufacturing the shots here. …
Read More »Oxford Covid-19 Vaccine May Become First To Gain Indian Regulator DCGI Approval For Emergency Use
With preparations underway for a possible launch of the vaccine in January, India’s drug regulator is looking to the UK, which sources say may give Oxford its go-ahead. COVID-19 vaccine next week, before deciding to give emergency use authorization to the Serum Institute that makes the injections here. Once the …
Read More »Oxford Covid Vaccine: Oxford Says Vaccine Has Good Immune Response With Two Dose Regimen | World News
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »Oxford Says Vaccine Has Good Immune Response With Two-Dose Regimen
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »PM Modi will be the first PM at the AMU event since 1964 | India News
AGRA: Prime Minister Narendra Modi will be the main guest at the celebrations of the 100 years of Muslim University of Aligarh, one of the oldest college teams in the country, on December 22. “A centenary is a milestone in the history of any university … The entire AMU community …
Read More »Oxford-AstraZeneca Covid Vaccine May Be Available in India for the First Half of Next Year: Official | India News
NEW DELHI: Oxford-AstraZeneca’s Covid-19 vaccine may be available in the country from the first half of next year, AstraZeneca Country President Gagandeep Singh said on Saturday. Speaking at the 93rd annual FICCI chamber of industry convention, he said that in the current pandemic, the vaccine must be available widely, equitably …
Read More »Rare, short-term allergic reactions to vaccines – health
Vaccines can sometimes cause allergic reactions, but they are usually rare and short-lived. British regulators are investigating reports of allergic reactions in two people who received the new Pfizer COVID-19 vaccine on Tuesday, the first day of a vaccination program. Meanwhile, they are telling people to skip the vaccine if …
Read More »AstraZeneca-Oxford First to Publish End Stage Vaccine Trial Results
The results are the “first full peer-reviewed efficacy results,” Lancet said. (Archive) Paris: Oxford University and AstraZeneca became the first Covid-19 vaccine manufacturers to publish the results of end-stage clinical trials in a scientific journal on Tuesday, clearing a key hurdle in the global race to produce safe and effective …
Read More »